Melatonin Prices

Melatonin Price Trend and Forecast

Track the latest insights on melatonin price trend and forecast with detailed analysis of regional fluctuations and market dynamics across Europe, North America, Middle East & Africa, Asia Pacific, and Latin America.

Melatonin Prices Q4 2024

During the last quarter of 2024, the melatonin prices in the United States reached 84,688 USD/MT in December. Due to the continued demand from the pharmaceutical and nutraceutical industries, melatonin prices in the United States showed a consistent increase in Q4 2024. High trade volumes and improvements in port efficiency supported this upward trend. Due to planned price adjustments made by domestic suppliers prior to the holiday season, December saw an increase in purchasing activity. Stable pharmaceutical demand and strong seasonal trends guaranteed supply chain stability, which helped to drive price increases during the quarter.

In the last quarter of 2024, melatonin prices in China remained mostly stable with minor fluctuations. The quarter ended with melatonin priced at 72,941 USD/MT in December. Despite consistent demand, melatonin prices in China gradually decreased as a result of muted market sentiment. The activity was momentarily interrupted by October's Golden Week. However, supply stability was preserved by proactive foreign imports. Although November's lower freight rates lowered expenses, they were unable to stop the pressure on prices to decline. Intense destocking in December caused prices to drop even more. Even while demand didn't change, continuous inventory adjustments kept prices down, which benefited purchasers.

Melatonin Prices Q4 2023

The price of melatonin in the United States for Q4 2023 reached 123,074 USD/MT in December. Among the key drivers were fluctuating demand, plentiful supply, rising freight costs, and reduced imports from Asia. Late in 2023, security issues in the Red Sea and a series of COVID-19 outbreaks in ports led to freight prices spiking, which impacted services and transit through the U.S., with further impact on the Panama Canal.

In the fourth quarter of 2023, melatonin prices in China reached 89,110 USD/MT in December. The prices exhibited a downward trend from October to November, followed by a slight increase in December due to improved economic indicators and seasonal restocking in anticipation of the Chinese Lunar New Year. In Q1 2024, the APAC melatonin market was stable despite flat pricing trends due to consistent demand from the pharmaceutical and nutraceutical sectors.

In the fourth quarter of 2023, Germany’s melatonin prices initially decreased due to surplus supply and reduced demand. The prices experienced a slight increase towards the end of the quarter driven by rising prices in China and growing local demand, settling at 90,816 USD/MT in December 2023. The trend in the European melatonin market in the fourth quarter of 2023 was mixed. The market was very prompt to face challenges early, as there were relatively high levels of supply, which compelled domestic companies to hold huge inventories in the run-up to the December holiday season.

Regional Coverage

The report provides a detailed analysis of the melatonin market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the melatonin price trend. 

Global Melatonin Price Trend

The report offers a holistic view of the global melatonin pricing trends in the form of melatonin price chart, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of melatonin but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed melatonin demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Melatonin Price Trend

Q4 2024:

In Q4 2024, supply-demand imbalances and inventory modifications influenced the melatonin market in Germany, resulting in erratic price swings. As end-user demand was still high and logistical challenges delayed timely supplies, prices increased at the start of the quarter. Despite limited supply, these variables enabled providers to raise prices, boosting profit margins strategically. Distributors and pharmaceutical purchasers were under pressure as the European supply chain experienced more stringent circumstances by mid-November.

Q4 2023:

During Q1 2024, the melatonin market in Germany faced declining prices, paralleling trends in the US and China. Contributing factors included volatile energy costs, interest rate hikes, supply chain disruptions from China, and currency depreciation. These elements, combined with inflationary pressures and federal taxes, created a challenging environment, leading to reduced demand and operational difficulties for market participants.

This analysis can be extended to include detailed melatonin price information for a comprehensive list of countries.

North America Melatonin Price Trend

Q4 2024:

Prices for melatonin increased steadily in the United States in the fourth quarter of 2024. The pharmaceutical and nutraceutical industries' steady purchasing activity was the main factor behind this. Throughout Q4, the market remained active, and a spike in new buyer inquiries further supported the price increase. Improved logistical efficiency and infrastructure upgrades at strategic ports helped to streamline supply chain operations, which supported the pricing trend. Demand was increased in December by deliberate price changes made in advance of the holidays, and domestic suppliers took advantage of the increased interest in the market. Consequently, export values increased due to notable levels of offtake in global markets.

Q4 2023:

In Q4 2023, North American melatonin prices declined due to subdued demand from nutraceutical and pharmaceutical sectors, oversupply, and reduced manufacturing output. High interest rates further dampened consumer confidence. In the US, melatonin prices fell from 130,400 USD/MT to 122,340 USD/MT FOB New Jersey, reflecting a -4% year-on-year decrease, despite positive job growth and declining unemployment rates.

Specific melatonin historical data within the United States and Canada can also be provided.

Middle East and Africa Melatonin Price Trend

The report explores the melatonin pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on melatonin prices for countries can also be provided.

Asia Pacific Melatonin Price Trend

Q4 2024:

Melatonin prices in China showed a steady decline in the latter quarter of 2024, mostly as a result of a combination of supply-side tactics and effects from global commerce. The October Golden Week vacation caused a brief lull in market activity at the start of the quarter. In spite of this, foreign purchasers took aggressive steps to pre-secure goods, guaranteeing that global supply lines would not be severely disrupted. Throughout the quarter, overall price trends were sluggish, despite some resilience from demand from Western markets.

Q4 2023:

In Q4 2023, the Asia-Pacific Melatonin market saw declining prices due to reduced demand from the pharmaceutical and nutraceutical sectors, particularly in China. Prices dropped from 91,700 USD/MT to 88,140 USD/MT FOB-Shanghai. Despite increased production, sluggish demand and lack of overseas inquiries contributed to the decline. Late improvements in China's PMI and consumer confidence led to a gradual price uptick.

This melatonin price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Melatonin Price Trend

Latin America's melatonin market is predominantly influenced by its rich natural reserves, particularly in countries like Chile and Brazil. However, political instability and inconsistent regulatory frameworks can lead to significant volatility in melatonin prices. Infrastructure challenges and logistical inefficiencies often impact the supply chain, affecting the region's ability to meet international demand consistently. Moreover, economic fluctuations and currency devaluation are critical factors that need to be considered when analyzing melatonin pricing trends in this region.

This comprehensive review can be extended to include specific countries within the region.

Melatonin Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Melatonin Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” offers an in-depth analysis of melatonin pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of melatonin at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of melatonin price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing melatonin price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Melatonin Industry Analysis

The global melatonin industry size reached US$ 398 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 1015.3 Billion, at a projected CAGR of 11.00% during 2023-2032.

• Increasing Prevalence of Sleep Disorders: A prominent factor that is increasing demand for melatonin supplements is the rising incidence of sleep disorders, such as insomnia and sleep apnea. The increasing consciousness regarding sound sleep and its impacts on life and health is making the majority of people opt for natural remedies which could include melatonin, aiming at improving overall sleep quality. This increasing trend is further supported by a number of research in line with melatonin's effectiveness in regulating one's sleep-wake cycle.
• The population of the entire world is increasing rapidly. It naturally increases the incidences of sleep-related issues in the elderly population. With increases in age, the problems of irregular sleep patterns become common. The elderly are ideal candidates for melatonin supplementation. So, as health providers increasingly see this supplement as a recommendation for their age-related sleep disturbances, the demographic changes further support growth in the market.
• Among natural hormones, melatonin is considered a better alternative to sleep medications. This, in turn, is propelling its demand. In addition, rising awareness toward non-pharmaceutical applications over the past years has driven demand for melatonin supplements.
• The nutraceuticals industry is proliferating due to the increased demand for dietary supplements, which are associated with overall health benefits. Melatonin is one of the key products popular in this sector due to its benefits for use in sleep medicines and general wellness. Moreover, the advancement in distribution networks, such as online platforms and retail stores, has helped better access to melatonin products.
• Improvement in supplement deliveries, such as time-release capsules, gummies, and liquids, makes melatonin products more palatable. These advances provide consumers with improved and more convenient ways to consume melatonin to cater to varying demands and requirement patterns. Improved delivery means are, therefore, fueling the market through the impact on improved product efficiency and customer experience.
• Melatonin supplements are being extensively used as an alternative, natural way to counter these conditions and help a person sleep better. Therefore, the rise in awareness of mental health is further fueling the intake of melatonin for stress-related sleep problems.
• As melatonin is identified by regulatory bodies across increasingly diverse geographies as a safe and efficacious supplement, the market environment turns increasingly positive. Instances of some of the regulatory support being available are within the context of enabling over-the-counter sales and the inclusion of melatonin within different health guidelines. Ease in entry and expansion in the market for melatonin products comes with favorable regulatory support.
• Consumers are switching to natural and organic supplements from synthetic pharmaceutical products. Melatonin, being a hormone that occurs naturally, rides this popularity. Clean-label products and sourcing data transparency is a further acting growth driver for melatonin supplements.
• Innovative marketing tactics and the power of social media drive sales of melatonin products. Brands take to various social media platforms to educate consumers on the benefits of melatonin while sharing testimonials and success stories. Influencers supporting melatonin through their endorsements and digital marketing campaigns are a strong motive for a young, health-conscious audience.
• Continuous research and development are trying to enhance the applications of melatonin outside sleep disorders. The treatment of diseases such as cancer, support to the immune system, and mental health, among others, are all areas of research interest. All these emerging applications are expected to open new market opportunities and drive the melatonin sector's growth even more.

Melatonin News

The report covers the latest developments, updates, and trends impacting the global melatonin industry, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in melatonin production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the melatonin price trend.

Latest developments in the melatonin industry:

• January 31, 2024: Biotics Research announced a strategic partnership with industry-leading hemp-derived cannabidiol (CBD) company Ananda Professional. This landmark partnership represents a pioneering milestone for each company, as Ananda Professional emerges as the exclusive marketer of Ananda Professional to the practitioner market.
• December 01, 2023: Pharmavite LLC has acquired Bonafide Health LLC, a company that develops and sells products related to women's health. The target company is based in the state of New York. Under the terms of the agreement, with the acquisition of Bonafide Health, Pharmavite will enhance its present portfolio in the area of women's health, which includes Uqora—a unique urinary tract health brand—and Equelle—the supplement with equol.
• June 23, 2023: Aurobindo Pharma announced that its wholly owned arm Eugia Pharma Specialties Ltd had entered into a voluntary sub-licensing agreement with Medicines Patent Pool (MPP) for the development and commercialization of an anti-cancer drug. It stated that, under the sub-licensing agreement's terms, Nilotinib capsules would be made available to 44 low and middle-income countries, seven of which currently have patent applications pending or in force for the product.

Product Description

Melatonin (C13H16N2O2) is a neurohormone produced from the pineal gland in the brain and is important for the regulation of the sleep-wake cycle. It is also available in the market as an over-the-counter dietary supplement for the purpose of treating sleep disorders, such as insomnia and jet lag. This supplement imitates the natural hormone in the body and helps readjust the internal clock. It is better than other supplements owing to its non-addictiveness and rather few or no significant side effects.

In addition, melatonin is associated with other health benefits, such as enhancement of eye health, management of depression in the seasonal period, and general enhancement of the immune by being an antioxidant. With such simple widespread use of melatonin, benefits for sleep improvement and general well-being become a powerful tool.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of melatonin price index, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting melatonin price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The melatonin price chart ensure our clients remain at the forefront of the industry.